Influencing Factors of Insulin Resistance in Polycystic Ovary Syndrome Patients with Normal Body Mass Index

Influencing Factors of Insulin Resistance in Polycystic Ovary Syndrome Patients with Normal Body Mass Index

Background The incidence of insulin resistance (IR) is higher in patients with polycystic ovary syndrome (PCOS) regardless of whether they are obese, which seriously affects their reproductive and metabolic health. At present, there are few studies on the influencing factors of IR in PCOS patients w...

Full description

Bibliographic Details
Main Author:	LUO Rong, WANG Yu, MIAO Afeng, WU Xiaoke
Format:	Article
Language:	zho
Published:	Chinese General Practice Publishing House Co., Ltd 2023-06-01
Series:	Zhongguo quanke yixue
Subjects:	polycystic ovary syndrome\|insulin resistance\|body mass index\|gonadal steroid hormones\|glucose metabolism disorders\|lipid metabolism disorders\|liver and kidney function\|electrolytic
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/1671501184002-473915702.pdf

Similar Items

Correlation Between Hemoglobin Levels and Polycystic Ovary Syndrome Metabolic Disorder
by: Ha LX, et al.
Published: (2023-09-01)

Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome
by: Ruihan Wang, et al.
Published: (2025-01-01)

The Efficacy of Yishen Quzhuo Formula Compared with Metformin in the Treatment of Polycystic Ovary Syndrome with Insulin Resistance: a Randomized Controlled Trial
by: LI Mengyuan, GAO Zheng, LIANG Jingqiao, ZHANG Yadong, LI Bo, XU Xin
Published: (2024-09-01)

Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome
by: Khulood Hussein, et al.
Published: (2023-06-01)

Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome
by: Mahnaz Ashrafi, et al.
Published: (2017-05-01)

Violation of the Hormonal Spectrum in Polycystic Ovaries in Combination with Insulin Resistance. What is the Trigger: Insulin Resistance or Polycystic Ovary Disease?
by: Lomteva S V, et al.
Published: (2022-10-01)

Association Between Insulin Resistance Indices and Liver Function Parameters Among Women With Polycystic Ovary Syndrome
by: Marzieh Saei Ghare Naz, et al.
Published: (2024-05-01)

Effect of subclinical hypothyroidism on endocrine and metabolic characteristics of patients with polycystic ovary syndrome
by: ZHANG Yuanmou, HAN Kang, XIA Rui, SUN Wenjian, REN Xiaoying, WANG Yan
Published: (2023-04-01)

The frequency and structure of metabolic disorders in obese women in combination with polycystic ovary syndrome
by: E. V. Bolotova, et al.
Published: (2021-10-01)

Relationship between Serum Lipids and Insulin Resistance among Women with Polycystic Ovary Syndrome
by: H Rashidi, et al.
Published: (2016-12-01)

Effect of polycystic ovary syndrome on increased risk of cardiovascular disease
by: Anna Maciak, et al.
Published: (2023-08-01)

Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
by: Marzena Jabczyk, et al.
Published: (2023-02-01)

The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study
by: Zhao H, et al.
Published: (2023-02-01)

Triglyceride and glucose index for identifying abnormal insulin sensitivity in women with polycystic ovary syndrome
by: Seeun Kwon, et al.
Published: (2023-07-01)

Interplay between lipid profile and anthropometric measures as indicators of cardiometabolic risk in women with polycystic ovary syndrome
by: Marzena Jabczyk, et al.
Published: (2024-11-01)

The role of immunity in insulin resistance in patients with polycystic ovary syndrome
by: Qixuan Zhang, et al.
Published: (2025-01-01)

Quercetin and polycystic ovary syndrome
by: Congshun Ma, et al.
Published: (2022-12-01)

MODERN CONCEPTS OF THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME (LITERATURE REVIEW)
by: O. V. Panarina, et al.
Published: (2017-07-01)

Features of correction of metabolic disorders in women with polycystic ovary syndrome
by: O.V. Bulavenko, et al.
Published: (2024-10-01)

The effect of Evening Primrose Oil on Changes in Polycystic Ovary Syndrome Induced by Estradiol Valerate in Rat
by: F Zand Vakili, et al.
Published: (2018-02-01)

The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial
by: Niloofar Ghanbarzadeh-Ghashti, et al.
Published: (2023-02-01)

Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome
by: Jin Yu, et al.
Published: (2023-01-01)

Broadening horizons: the role of ferroptosis in polycystic ovary syndrome
by: Min Wang, et al.
Published: (2024-08-01)

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study
by: Manman Pan, et al.
Published: (2023-08-01)

Antioxidant supplements relieve insulin resistance but do not improve lipid metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials
by: Ruye Wang, et al.
Published: (2022-12-01)

Valproate, Menstrual Disorder and Polycystic Ovaries
by: J Gordon Millichap
Published: (2000-08-01)

Serum adiponectin level is negatively related to insulin resistance in women with polycystic ovary syndrome
by: Jie Yang, et al.
Published: (2024-12-01)

Triglyceride-glucose index is associated with metabolic syndrome in women with polycystic ovary syndrome
by: Haiyan Yang, et al.
Published: (2023-12-01)

Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism
by: Huize Chen, et al.
Published: (2023-05-01)

Lipid Profile In Relation To Anthropometric Indices and Insulin Resistance in Overweight Women with Polycystic Ovary Syndrome
by: Maryam Saghafi-Asl, et al.
Published: (2013-12-01)

Relationship of adiponectin, leptin and reproductive endocrine hormones with insulin resistance in polycystic ovary syndrome patients with normal BMI
by: Weiwei Feng, et al.
Published: (2024-12-01)

THE SPECTRUM OF BIOCHEMICAL, HORMONAL, AND METABOLIC CHANGES – A DETERMINING FACTOR IN THE MANAGEMENT OF PSYCHOSOCIAL AND MEDICAL IMPLICATIONS OF POLYCYSTIC OVARY SYNDROME
by: Anca Daniela Brăila, et al.
Published: (2024-09-01)

Association between insulin resistance and abnormal menstrual cycle in Chinese patients with polycystic ovary syndrome
by: Jiali Niu, et al.
Published: (2023-02-01)

Evaluation of Insulin and Estradiol in Women with Polycystic Ovary Syndrome and its Relationship With BMI
by: Hiva Danesh, et al.
Published: (2021-11-01)

Insulin resistance and adverse metabolic profile in overweight/obese and normal weight of young women with polycystic ovary syndrome
by: Maryam Gholinezhad, et al.
Published: (2018-05-01)

Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome
by: Xinling Wen, et al.
Published: (2024-07-01)

The Relationship between Gestational Diabetes and Polycystic Ovary Syndrome
by: R Nikbakht, et al.
Published: (2018-04-01)

Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran
by: Ziba Zahiri, et al.
Published: (2016-01-01)

Metabolic syndrome in women with polycystic ovary syndrome
by: Khalid Ibrahim Al - Lehibi, et al.
Published: (2011-06-01)

Anthropometric Characteristics of Polycystic Ovary Syndrome and Their Associations with Insulin Resistance and Lipid Profile
by: María L. Sánchez-Ferrer, et al.
Published: (2021-06-01)